Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-004877
Filing Date
2025-04-16
Accepted
2025-04-16 07:00:29
Documents
17
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A pasg-20250528xdef14a.htm   iXBRL DEF 14A 779405
2 GRAPHIC pasg-20250528xdef14a_a001.jpg GRAPHIC 5718
3 GRAPHIC pasg-20250528xdef14a_bg001.jpg GRAPHIC 117847
4 GRAPHIC pasg-20250528xdef14a_bg002.jpg GRAPHIC 92718
  Complete submission text file 0001558370-25-004877.txt   1585550

Data Files

Seq Description Document Type Size
5 EX-101.SCH pasg-20250528.xsd EX-101.SCH 3574
6 EX-101.LAB pasg-20250528_lab.xml EX-101.LAB 634
7 EX-101.PRE pasg-20250528_pre.xml EX-101.PRE 1847
20 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20250528xdef14a_htm.xml XML 5817
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39231 | Film No.: 25841195
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)